Site Search

Biomarker testing is an important step to accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. However, not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. ... that prevent patients from benefiting from biomarker testing and precision medicine, and working to ensure all patients benefit, regardless of race, ethnicity, gender, age, sexual orientation, socioeconomic status, or zip code.   ACS CAN conducted a survey of 315 oncology providers ...

BOISE, Idaho – – A bill that would serve to strip health care from thousands of hard-working Idahoans will be heard by the Health & Welfare Committee of the Idaho House of Representatives on Tuesday. House Bill 345 would ... their treatment plans and keep others from potentially life-saving screenings and regular visits with their health care providers.  Idaho ACS CAN advocates urge lawmakers to adhere to the will of the voters and the hundreds who have testified previously against similar legislation.   ... sources and requiring more frequent paperwork from enrollees just adds to government red tape and confusion for Medicaid enrollees.  From a cost-benefit perspective, this all adds to the staffing and infrastructure burdens of the Department of Health and Welfare with no clear benefit to ...

ACS CAN Colorado State and Local Advocacy Accomplishments 2010-2017     2010 As supported by ACS CAN, the Colorado Legislature passed a bill that requires health insurance companies who provide coverage for intravenous chemotherapy to also provide coverage for newer types of oral chemotherapy agents, furthermore requiring that insurance policies provide those benefits at an out-of-pocket cost to the patient that is no costlier than IV chemotherapy under that patient’s policy. 2011 ACS CAN successfully advocated for the adoption of ...

... I attended on Capitol Hill with IBM and MD Anderson about how technology innovation could help end cancer. Technology is changing every aspect of our lives, and in the field of medicine that is especially true in the diagnosis, treatment and prevention of cancer. Technology allowed ... applying technology in unprecedented ways. Watson is a groundbreaking example of how the synthesis of big data into new forms of intelligence can teach us more about diseases, treatments and patients themselves. Watson has the potential to revolutionize oncology research with its ability ... Š—– and one that can be replicated by different doctors in similar patients wherever they are. The promise is better quality care and lower cost. A cognitive technology platform like Watson can hold that kind of potential. An estimated 1.6 million people in America will be diagnosed ...